| Ticker Details |
|
GRAIL, Inc. Common Stock
|
| IPO Date: |
June 25, 2024 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$2.57B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.06 | 4.73%
|
| Avg Daily Range (30 D): |
$2.49 | 4.10%
|
| Avg Daily Range (90 D): |
$2.97 | 4.59%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.05M |
| Avg Daily Volume (30 D): |
.66M |
| Avg Daily Volume (90 D): |
.98M |
| Trade Size |
| Avg Trade Size (Sh.): |
64 |
| Avg Trade Size (Sh.) (30 D): |
47 |
| Avg Trade Size (Sh.) (90 D): |
53 |
| Institutional Trades |
| Total Institutional Trades: |
961 |
| Avg Institutional Trade: |
$3.06M |
| Avg Institutional Trade (30 D): |
$2.9M |
| Avg Institutional Trade (90 D): |
$3.56M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.58M |
| Avg Closing Trade (30 D): |
$5.09M |
| Avg Closing Trade (90 D): |
$6.39M |
| Avg Closing Volume: |
100.01K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-10.3
|
$-2.29
|
$-2.38
|
|
Diluted EPS
|
$-10.3
|
$-2.29
|
$-2.38
|
|
Revenue
|
$156.12M
|
$40.79M
|
$43.6M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-395.33M
|
$-93.19M
|
$-99.18M
|
|
Operating Income / Loss
|
$-544.32M
|
$-135.77M
|
$-124.41M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$39.14M
|
$-.04M
|
$38.97M
|
|
PE Ratio
|
|
|
|
|
|
|